Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Liver Diseases of Pregnancy
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
Related Questions
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
What management considerations do you keep in mind in the management of pregnant patients with autoimmune liver disease?
When would you plan to biopsy a hepatic adenoma to see if it has high risk features/mutations?
How do you approach the use of viscoelastic assays (ex: TEG, ROTEM) in patients with identified coagulopathy in the peri-procedural period?
How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
What clinical evidence do you find most favorable of a positive response post-liver transplant for patients with portopulmonary hypertension?
In what scenario do you screen patients with hepatitis B for hepatitis D co-infection?
How do you approach the surveillance and serologic evaluation of a patient in whom you suspect has a hepatitis B pre-core mutant?